The window of opportunity in ACPA-positive rheumatoid arthritis is not explained by ACPA characteristics

Author(s):
Willemze, A.; Linden, M.P.M. van der; Cessie, S. le (0000-0003-2154-4923); Trouw, L.A. (0000-0001-5186-2290); Toes, R.E.M. (0000-0002-9618-6414); Huizinga, T.W.J. (0000-0001-7033-7520); Helm-van Mil, A.H.M. van der
Published
2011
Publication type
Article / Letter to editor
citrullinated protein antibody fine specificity shared epitope disease therapy delay
Date issued
2011-09-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2011), Vol. 70, no. 9, p. 1697
hdl
1887/110871
doi
10.1136/ard.2010.148312